Subsequently, we observed we that OSCC with lymph node metastasis had a stronger immunoreactivity than OSCC without lymph node metastasis, and the expression of MELK was higher in metastatic lymph nodes than in the original tumour. This evidence concerns the gene MELK and neoplasm.